HK1038069A1 - Immunoassay for c.reactive protein - Google Patents

Immunoassay for c.reactive protein

Info

Publication number
HK1038069A1
HK1038069A1 HK01109045A HK01109045A HK1038069A1 HK 1038069 A1 HK1038069 A1 HK 1038069A1 HK 01109045 A HK01109045 A HK 01109045A HK 01109045 A HK01109045 A HK 01109045A HK 1038069 A1 HK1038069 A1 HK 1038069A1
Authority
HK
Hong Kong
Prior art keywords
immunoassay
antibody
antiidiotypic
reactive protein
monoclonal antibody
Prior art date
Application number
HK01109045A
Other languages
English (en)
Inventor
Edward R Scalice
John L Daiss
Original Assignee
Ortho Clinical Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Clinical Diagnostics Inc filed Critical Ortho Clinical Diagnostics Inc
Publication of HK1038069A1 publication Critical patent/HK1038069A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/686—Anti-idiotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4737—C-reactive protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/965—Chemistry: molecular biology and microbiology involving idiotype or anti-idiotype antibody
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK01109045A 2000-03-31 2001-12-24 Immunoassay for c.reactive protein HK1038069A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19395100P 2000-03-31 2000-03-31

Publications (1)

Publication Number Publication Date
HK1038069A1 true HK1038069A1 (en) 2002-03-01

Family

ID=22715702

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01109045A HK1038069A1 (en) 2000-03-31 2001-12-24 Immunoassay for c.reactive protein

Country Status (8)

Country Link
US (1) US6838250B2 (de)
EP (1) EP1139101B1 (de)
JP (1) JP5031148B2 (de)
AT (1) ATE314653T1 (de)
DE (1) DE60116172T2 (de)
DK (1) DK1139101T3 (de)
ES (1) ES2254330T3 (de)
HK (1) HK1038069A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1565570A4 (de) 2002-11-12 2005-12-28 Becton Dickinson Co Sepsis- oder sirs-diagnose mittels biomarkerprofilen
US20050136055A1 (en) 2003-12-22 2005-06-23 Pfizer Inc CD40 antibody formulation and methods
US20060154276A1 (en) 2004-05-13 2006-07-13 Prometheus Laboratories Inc. Methods of diagnosing inflammatory bowel disease
JP4956705B2 (ja) * 2004-07-02 2012-06-20 株式会社三和化学研究所 免疫測定装置及び方法
BRPI0609302A2 (pt) 2005-04-15 2011-10-11 Becton Dickinson Co métodos para prever o desenvolvimento de sepse e para diagnosticar sepse em um indivìduo a ser testado, microarranjo, kit para prever o desenvolvimento de sepse em um indivìduo a ser testado, produto de programa de computador, computador, sistema de computador para determinar se um indivìduo é susceptìvel de desenvolver sepse, sinal digital embutido em uma onda portadora, e, interface gráfica de usuário para determinar se um indivìduo é susceptìvel de desenvolver sepse
US20060246522A1 (en) * 2005-04-28 2006-11-02 Bhullar Balwant S C-reactive protein immunoassay and method
JP5097557B2 (ja) * 2005-12-22 2012-12-12 ローム株式会社 免疫測定装置及び方法
US8383350B1 (en) 2006-12-20 2013-02-26 Merck Sharp & Dohme Corp. Assay for detection of IL-10 antibodies
CN101802005B (zh) * 2007-08-28 2015-09-16 艾伯维生物技术有限公司 包括关于阿达木单抗的结合蛋白质的组合物和方法
JP4970217B2 (ja) * 2007-11-07 2012-07-04 株式会社東芝 物質の測定方法
WO2009123737A2 (en) 2008-04-03 2009-10-08 Becton, Dickinson And Company Advanced detection of sepsis
JP5265257B2 (ja) * 2008-06-30 2013-08-14 富士フイルム株式会社 犬ｃｒｐ及び人ｃｒｐを認識する抗体
AU2009314259B2 (en) 2008-11-11 2015-06-11 Nestec S.A. Methods for prediction of inflammatory bowel disease (IBD) using serologic markers
WO2010058860A1 (ja) * 2008-11-18 2010-05-27 株式会社シノテスト 試料中のｃ反応性蛋白質の測定方法及び測定試薬
WO2010120814A1 (en) 2009-04-14 2010-10-21 Prometheus Laboratories Inc. Inflammatory bowel disease prognostics
CA2766157A1 (en) 2009-06-25 2010-12-29 Hua Gong Methods for diagnosing irritable bowel syndrome
WO2011060098A1 (en) 2009-11-10 2011-05-19 Prometheus Laboratories Inc. Methods for predicting post-surgery risk associated with ileal pouch-anal anastomosis
PT2569013T (pt) 2010-05-14 2017-02-08 Univ Leland Stanford Junior Anticorpos monoclonais humanizados e quiméricos para cd47
EP2630495B1 (de) 2010-10-18 2017-02-08 Nestec S.A. Verfahren zur bestimmung von gegen medikamente gerichtete antikörperisotypen
WO2012154253A1 (en) 2011-02-17 2012-11-15 Prometheus Laboratories Inc. ASSAYS FOR DETECTING AUTOANTIBODIES TO ANTI-TNFα DRUGS
JP2014516944A (ja) 2011-04-29 2014-07-17 ブリストル−マイヤーズ スクイブ カンパニー Ｉｐ１０抗体の用量漸増計画
BR112013028808A2 (pt) 2011-05-10 2016-09-06 Nestec Sa métodos de caracterização de perfil de atividade de doença para a gestão de terapia personalizada
WO2013059732A1 (en) 2011-10-21 2013-04-25 Nestec S.A. Methods for improving inflammatory bowel disease diagnosis
HUE037186T2 (hu) 2011-12-28 2018-08-28 Immunoqure Ag Eljárás humán antitestek izolálására
AU2013326070A1 (en) 2012-10-05 2015-04-23 Société des Produits Nestlé S.A. Methods for predicting and monitoring mucosal healing
KR20160013163A (ko) 2013-05-24 2016-02-03 네스텍 소시에테아노님 과민성 대장 증후군 진단을 예측하기 위한 경로 특이적 검정법
KR102402973B1 (ko) 2013-07-03 2022-05-27 이뮤노큐어 아게 인간 항-ifn-알파 항체
JP6446044B2 (ja) 2013-11-05 2018-12-26 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 結合分子の存在下で被検体の総量および／または総濃度を決定するための方法、ならびにそれに関係するキット、組成物および使用
EP3077818B1 (de) 2013-12-03 2020-02-05 Prometheus Biosciences, Inc. Verfahren zur vorhersage des postoperativen wiederauftretens von morbus crohn
WO2015166461A1 (en) 2014-05-01 2015-11-05 Nestec S.A. Methods of selecting treatment regimen using tnf alpha and anti-tnf alpha drug levels
MX2017006959A (es) 2014-12-02 2017-08-10 Nestec Sa Metodos para establecer un regimen de dosificacion de vedolizumab para tratar pacientes con enfermedad del intestino irritable.
CA3011215A1 (en) 2015-11-06 2017-05-11 Vetica Labs, Inc. Methods of detecting inflammatory markers and treating inflammatory conditions in companion animals
CN108279229B (zh) * 2017-01-05 2024-02-27 深圳市帝迈生物技术有限公司 一种全血crp检测装置
JP7328960B2 (ja) 2017-10-10 2023-08-17 プロメテウス バイオサイエンシーズ インコーポレイテッド ベドリズマブ処置をモニタリングするための方法
CN112051403A (zh) * 2020-08-27 2020-12-08 武汉生之源生物科技股份有限公司 C反应蛋白化学发光免疫检测试剂盒及其制备方法和应用
EP4357778A1 (de) 2022-10-20 2024-04-24 Heraeus Medical GmbH Behandlung von mikrobiellen infektionen mit diagnose durch biomarker d-lactat

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219730A (en) 1982-09-28 1993-06-15 New York University Idiotype-anti-idiotype immunoassay
US4828981A (en) * 1983-08-24 1989-05-09 Synbiotics Corporation Immunoassays for determining Dirofilaria immitis infection using antiidiotype monoclonal antibody reagents
US4699880A (en) 1984-09-25 1987-10-13 Immunomedics, Inc. Method of producing monoclonal anti-idiotype antibody
DE3685377D1 (de) * 1985-07-22 1992-06-25 Abbott Lab Fluoreszenz-polarisation-immunotest und reagens zur messung von c-reaktivem protein.
AU642430B2 (en) 1989-06-27 1993-10-21 Rush - Presbyterian - St. Luke's Medical Center Monoclonal antibodies to c-reactive protein
JP3174402B2 (ja) * 1992-06-08 2001-06-11 三洋化成工業株式会社 競合法による免疫測定法および測定用キット
JPH10282098A (ja) * 1997-04-11 1998-10-23 Matsushita Electric Ind Co Ltd 蛍光免疫測定法

Also Published As

Publication number Publication date
EP1139101A3 (de) 2002-05-15
US20020142356A1 (en) 2002-10-03
ES2254330T3 (es) 2006-06-16
EP1139101A9 (de) 2002-03-20
EP1139101B1 (de) 2005-12-28
JP2002040024A (ja) 2002-02-06
EP1139101A2 (de) 2001-10-04
DE60116172T2 (de) 2006-08-03
DK1139101T3 (da) 2006-04-10
DE60116172D1 (de) 2006-02-02
ATE314653T1 (de) 2006-01-15
US6838250B2 (en) 2005-01-04
JP5031148B2 (ja) 2012-09-19

Similar Documents

Publication Publication Date Title
HK1038069A1 (en) Immunoassay for c.reactive protein
NZ547157A (en) Interferon Alpha Antibodies and their uses
RS50477B (sr) Anti-il-12 antitela, kompozicije, metode i njihove upotrebe
UA89017C2 (uk) ЛЮДСЬКЕ АНТИТІЛО, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ЛЮДСЬКИМ TNFSF13b
HK1045729A1 (en) Early detection of flavivviruses using the ns1 glycoprotein.
ATE384792T1 (de) Antikörpervarianten mit höheren bindungsaffinitäten im vergleich zu parentalen antikörpern
WO2003074679A3 (en) Antibody optimization
EA200400510A1 (ru) Агенты, специфически связывающие ангиопоэтин-2
HK1078647A1 (en) Analytical sandwich test for determining nt-probnp
GB2383331A (en) Monoclonal antibody DS6 Tumor-associated antigen CA6 and methods of use thereof
WO2004025248A3 (en) Antibody pair screening methods
EP1378525A3 (de) Humanisierte Antikörper die and das gleiche Antigen wie Antikörper NR-LU-13 binden und deren Verwendung in "Pretargeting" Verfahren
HK1132750A1 (en) Monoclonal antibodies, cross-reactive antibodies and method for producing the same
DE602005026571D1 (de) Tumornekrosefaktor-alpha spezifische humanisierte antikörper
EP2186884A3 (de) Monoklonale Antikörpergegen HCV Kernantigen
WO1998023955A3 (de) ANTIGENSPEZIFISCHER IgM-NACHWEIS
WO2006015098A3 (en) Taxol immunoassay
DK1167389T3 (da) Antistoffer mod SEMP1-proteinet, fremgangsmåde til fremstilling heraf samt anvendelse deraf
NO20051715L (no) HCV assay
IL154000A (en) A method that uses antibodies to diagnose arthritis
IL108607A0 (en) Preparation of photoprotein conjugates and methods of use thereof
EP1326895B8 (de) Monoklonale antikörper gegen hepatitis b virus
NO174153C (no) Antigen og monoklonalt antistoff for anvendelse in vitro, samt immunologiske reagenser inneholdende disse
WO2002076406A3 (en) Antibodies against autoantigens of primary biliary cirrhosis and methods of making and using them
WO2002023202A3 (en) Method to identify antibody targets based on mass spectrometry (maldi-tof)

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100330